Neurocrine Biosciences has presented new one-year data from its Phase III CAHtalyst Adult study of Crenessity (crinecerfont) ...

OMS1620 is advancing through IND-enabling studies for diseases associated with ACTH excess, including congenital adrenal ...

Results from the Phase III CAHtalyst show that patients treated with Crenessity for classic congenital adrenal hyperplasia ...

Adrenal hormone function was restored in animal studies, potentially paving the way for a functional cure for primary adrenal insufficiency in humans, according to research being presented by Aspect ...

Effects of adrenal cortical hormone (17-hydroxy-dehydro-corticosterone: cortisone) and of pituitary adrenocorticotropic hormone (ACTH) on rheumatoid arthritis and rheumatic fever.

Adrenal hormone function was restored in animal studies, potentially paving the way for a functional cure for primary adrenal ...

The Adrenocorticotropic Hormone (ACTH) report, brimming with the latest market insights and analyses, serves as a beacon, bringing clarity to the marketplace. This comprehensive market research study ...

Alcohol and caffeine also impact your cortisol levels, and consuming too much of either or both over time impacts your cortisol levels. Alcohol increases inflammation, which places stress on the body, ...

Researchers have successfully converted human pluripotent stem cells into purified pituitary cells that aggregated into hormone-secreting organoids. As reported June 8 in the journal Stem Cell ...

Global Adrenocorticotropic Hormone (ACTH) Market is poised to reach an impressive US$ 2.3 Billion by 2030, exhibiting a remarkable CAGR of 4.10% from 2023 to 2030.